share_log

Needham Maintains Buy on Veracyte, Raises Price Target to $44

Benzinga ·  Nov 7 05:48  · Ratings

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $37 to $44.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment